Dermapharm Holding SE banner

Dermapharm Holding SE
DUS:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
DUS:DMP
Watchlist
Price: 47.15 EUR -2.78% Market Closed
Market Cap: €5B

Wall St Price Targets

DMP Price Targets Summary
Dermapharm Holding SE

Wall Street analysts forecast DMP stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DMP is 41.73 EUR with a low forecast of 34.27 EUR and a high forecast of 50.29 EUR.

Lowest Forecast
Price Target
34.27 EUR
27% Downside
Average Forecast
Price Target
41.73 EUR
11% Downside
Highest Forecast
Price Target
50.29 EUR
7% Upside
Dermapharm Holding SE Competitors:
Price Targets

Revenue
Forecast

12% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.

Gross Profit
Forecast

16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Dermapharm Holding SE

Operating Income
Forecast

13% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
13% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 7%.

Pre-Tax Income
Forecast

13% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
13% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Dermapharm Holding SE

Net Income
Forecast

26% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
26% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 5%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DMP's stock price target?
Price Target
41.73 EUR

According to Wall Street analysts, the average 1-year price target for DMP is 41.73 EUR with a low forecast of 34.27 EUR and a high forecast of 50.29 EUR.

What is the Revenue forecast for Dermapharm Holding SE?
Projected CAGR
5%

Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.

What is the Operating Income forecast for Dermapharm Holding SE?
Projected CAGR
7%

Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 7%.

What is the Net Income forecast for Dermapharm Holding SE?
Projected CAGR
5%

Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 5%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett